Answers are grounded in this paper and cite their sources.
Retrospective cohort study finds pre-donation plasma aldosterone to renin ratio predicts systolic hypertension in living kidney donors, suggesting implications for donor health.
Introduction: Hypertension (HTN) is one of the most common long-term medical complications in living kidney donors (LKD). There exists a clinical need for a model to predict the severity of hypertension and adverse health effects pre-donation. Aldosterone and renin have long been implicated in the pathogenesis of HTN, but little is known about their association in LKD. Hypothesis: We aim to examine the association between pre-donation plasma aldosterone concentration: plasma renin activity ratio (PAC/PRA) and post-donation HTN time to hypertensive event (SBP>=130 mmHg or DBP>=80 mmHg). Methods: A single-center retrospective cohort study included LKD candidates undergoing unilateral native nephrectomy between 9/7/2021 and 8/21/2024 and having BP measurements at 6, 12, or 24 months post-donation. Multivariable Cox regression was used to examine the association between PAC/PRA and time-to-developing systolic or diastolic HTN (SHTN or DHTN) defined by SBP ≥130 or DBP ≥80 mmHg. Results: Of 50 LKD, the mean±SD age at donation was 51±12 years, and 58% were female. The mean PAC, PRA, and PAC/PRA were 11.92±5.80 ng/dL, 1.30±1.06 ng/mL/h, and 16.50±18.26, respectively (Figure 1). Mean BP were 118/72, 121/76, 119/74, and 123/75 mmHg at pre-donation, 6, 12, and 24 months post-donation, respectively (Figure 2) With a median follow-up time of 9.4 months post donation, 52% developed HTN. Up to 36% experienced SHTN, while 42% had DHTN. Median time to developing post-donation SHTN and DHTN were 11.62 and 11.32 months, respectively. After adjusting for age, gender, race/ethnicity, BMI, BUN, dietary sodium intake, dietary potassium intake, dietary protein intake, eGFR, thyroid-stimulating hormone, triiodothyronine, total cholesterol, triglyceride, HDL, and LDL, every 1 unit increase in PAC/PRA was associated with 85% decrease in post-donation SHTN (aHR 1.149, 95%CI 1.100, 1.200; P <0.00001; Figure 3). There was no significant PAC/PRA – DHTN association. Conclusions: Pre-donation PAC/PRA is positively associated with post-donation SHTN, but not DHTN. Further longitudinal studies are required to elucidate the potential mechanism for the association.
No takes yet. Share an insight, caveat, or question.
Gangeddula et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: